Cargando…

Clinical Utility of SARS-CoV-2 Antibody Titer Multiplied by Binding Avidity of Receptor-Binding Domain (RBD) in Monitoring Protective Immunity and Clinical Severity

Conventional serum antibody titer, which expresses antibody level, does not provide antigen binding avidity of the variable region of the antibody, which is essential for the defense response to infection. Here, we quantified anti-SARS-CoV-2 antibody binding avidity to the receptor-binding domain (R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, Etsuhisa, Sawabuchi, Takako, Homma, Tetsuya, Fukuda, Yosuke, Sagara, Hironori, Kinjo, Takeshi, Fujita, Kaori, Suga, Shigeru, Kimoto, Takashi, Sakai, Satoko, Kameda, Keiko, Kido, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459795/ https://www.ncbi.nlm.nih.gov/pubmed/37632005 http://dx.doi.org/10.3390/v15081662

Ejemplares similares

Induction of systemic, mucosal, and cellular immunity against SARS‐CoV‐2 in mice vaccinated by trans‐airway with a S1 protein combined with a pulmonary surfactant‐derived adjuvant SF‐10
por: Kimoto, Takashi, et al.
Publicado: (2023)

A Murine Model of Food Allergy by Epicutaneous Adjuvant-Free Allergen Sensitization Followed by Oral Allergen Challenge Combined with Aspirin for Enhanced Detection of Hypersensitivity Manifestations and Immunotherapy Monitoring
por: Kameda, Keiko, et al.
Publicado: (2023)

Adjuvanting influenza hemagglutinin vaccine with a human pulmonary surfactant-mimicking synthetic compound SF-10 induces local and systemic cell-mediated immunity in mice
por: Kim, Hyejin, et al.
Publicado: (2018)

Binding Revisited—Avidity in Cellular Function and Signaling
por: Erlendsson, Simon, et al.
Publicado: (2021)

Clinical inertia in asthma
por: Fukuda, Yosuke, et al.
Publicado: (2023)

Orchestrating Binding Interactions and the Emergence of Avidity Driven Therapeutics
por: Kapcan, Eden, et al.
Publicado: (2023)

Entropic contribution of ACE2 glycans to RBD binding
por: Mugnai, Mauro L., et al.
Publicado: (2023)

Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection
por: Tauzin, Alexandra, et al.
Publicado: (2022)

Frequency and avidity of specific antigen-binding cells in developing mice
Publicado: (1975)

High-avidity binding drives nucleation of amyloidogenic transthyretin monomer
por: Gao, Li, et al.
Publicado: (2022)

Novel Decapeptides that Bind Avidly and Deliver Radioisotope to Colon Cancer Cells
por: Abraham, John M., et al.
Publicado: (2007)

Cholesterol enhances influenza binding avidity by controlling nanoscale receptor clustering
por: Goronzy, I. N., et al.
Publicado: (2018)

Correlation between Commercial Anti-RBD IgG Titer and Neutralization Titer against SARS-CoV-2 Beta Variant
por: Poon, Rosana Wing-Shan, et al.
Publicado: (2021)

Interference of daratumumab with pretransfusion testing, mimicking a high-titer, low avidity like antibody
por: Lin, Mei-Hwa, et al.
Publicado: (2017)

Longitudinal antibody titer, avidity, and neutralizing responses after SARS-CoV-2 infection
por: Monroe, Jonathon M., et al.
Publicado: (2022)

Ligand Binding Sites of Inducible Costimulator and High Avidity Mutants with Improved Function
por: Wang, Shengdian, et al.
Publicado: (2002)

Self-Assembling Lectin Nano-Block Oligomers Enhance Binding Avidity to Glycans
por: Irumagawa, Shin, et al.
Publicado: (2022)

Diagnosing and mitigating method-based avidity artifacts that confound polyubiquitin-binding assays
por: Schoeffler, Allyn J., et al.
Publicado: (2021)

Immunomodulator Clarithromycin Enhances Mucosal and Systemic Immune Responses and Reduces Re-Infection Rate in Pediatric Patients with Influenza Treated with Antiviral Neuraminidase Inhibitors: A Retrospective Analysis
por: Shinahara, Wakako, et al.
Publicado: (2013)

Cadonilimab, a tetravalent PD-1/CTLA-4 bispecific antibody with trans-binding and enhanced target binding avidity
por: Pang, Xinghua, et al.
Publicado: (2023)

Avidity of IgG to SARS-CoV-2 RBD as a Prognostic Factor for the Severity of COVID-19 Reinfection
por: Manuylov, Victor, et al.
Publicado: (2022)

Differential avidity determination of IgG directed towards the receptor‐binding domain (RBD) of SARS‐CoV‐2 wild‐type and its variants in one assay: Rational tool for the assessment of protective immunity
por: Bauer, Georg, et al.
Publicado: (2022)

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
por: Tai, Wanbo, et al.
Publicado: (2020)

Freezing adhesion molecules in a state of high-avidity binding blocks eosinophil migration
Publicado: (1993)

T Cell Receptor Signaling Can Directly Enhance the Avidity of CD28 Ligand Binding
por: Sanchez-Lockhart, Mariano, et al.
Publicado: (2014)

How the avidity of polymerase binding to the –35/–10 promoter sites affects gene expression
por: Einav, Tal, et al.
Publicado: (2019)

Noncovalent antibody catenation on a target surface greatly increases the antigen-binding avidity
por: Song, Jinyeop, et al.
Publicado: (2023)

The SARS-CoV-2 mRNA-1273 vaccine elicits more RBD-focused neutralization, but with broader antibody binding within the RBD
por: Greaney, Allison J., et al.
Publicado: (2021)

COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants
por: Junker, Daniel, et al.
Publicado: (2022)

Enhancement of binding avidity by bivalent binding enables PrP(Sc)-specific detection by anti-PrP monoclonal antibody 132
por: Suzuki, Akio, et al.
Publicado: (2019)

Analysis of the Microprocessor in Dictyostelium: The Role of RbdB, a dsRNA Binding Protein
por: Meier, Doreen, et al.
Publicado: (2016)

SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape
por: Yang, Lin, et al.
Publicado: (2021)

Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes
por: Fan, Chengcheng, et al.
Publicado: (2022)

Cross-species binding spectrum of ACE2 to SARS-CoV-2 RBD
por: Liao, Xihao, et al.
Publicado: (2022)

High Heterogeneity of Virus-Neutralizing and RBD-Binding Activities of COVID-19 Convalescent Sera
por: Astakhova, E. A., et al.
Publicado: (2022)

Exploring the disruption of SARS-CoV-2 RBD binding to hACE2
por: Carter, Camryn, et al.
Publicado: (2023)

Avid interactions underlie the K63-linked polyubiquitin binding specificities observed for UBA domains
por: Sims, Joshua J., et al.
Publicado: (2009)

Simple electrochemical sensing of attomolar proteins using fabricated complexes with enhanced surface binding avidity
por: Li, Chao, et al.
Publicado: (2015)

IL-1β is a key cytokine that induces trypsin upregulation in the influenza virus–cytokine–trypsin cycle
por: Indalao, I. L., et al.
Publicado: (2016)

Correction to: IL-1b is a key cytokine that induces trypsin upregulation in the influenza virus–cytokine–trypsin cycle
por: Indalao, I. L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rdd0dnn9o6rrp1g9sou1op3d39